Clinical Trial Update: MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updates MC5-A Scrambler Therapy for reducing chemotherapy-induced peripheral neuropathy, with results posted after the study's completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• MC5-A Scrambler Therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Pain, Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2014-03-05